These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 9740093)

  • 1. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis.
    Bartlett DL; Buell JF; Libutti SK; Reed E; Lee KB; Figg WD; Venzon DJ; Alexander HR
    Cancer; 1998 Sep; 83(6):1251-61. PubMed ID: 9740093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
    Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
    Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
    Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
    Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis.
    Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Takahashi M
    Hepatogastroenterology; 2006; 53(69):473-8. PubMed ID: 16795995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.
    Cattel L; De Simone M; Passera R; Verlengo MC; Delprino L
    Anticancer Res; 2004; 24(3b):2041-5. PubMed ID: 15274398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP).
    Park BJ; Alexander HR; Libutti SK; Wu P; Royalty D; Kranda KC; Bartlett DL
    Ann Surg Oncol; 1999 Sep; 6(6):582-90. PubMed ID: 10493628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis.
    Cho HK; Lush RM; Bartlett DL; Alexander HR; Wu PC; Libutti SK; Lee KB; Venzon DJ; Bauer KS; Reed E; Figg WD
    J Clin Pharmacol; 1999 Apr; 39(4):394-401. PubMed ID: 10197298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S; Deraco M; Baratti D; Inglese MG; Costanzo P; Favaro M; Manzi R; Gavazzi C
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
    Zeamari S; Floot B; van der Vange N; Stewart FA
    Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C for peritoneal dissemination in gastric cancer].
    Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1415-24. PubMed ID: 2509604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination].
    Kusano H; Miyashita K; Matsuo T; Jibiki M; Nakagoe T; Miura T; Tomita M
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1622-5. PubMed ID: 8373233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic results and pharmacokinetics of combined used anticancer drug in intraperitoneal hyperthermo-chemotherapy (CHPP)].
    Inoue Y; Yamashiro H; Sawada T; Murakami A; Hamazoe R; Shimizu N; Maeta M; Kaibara N
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1551-4. PubMed ID: 2389947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
    Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
    Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal protection with amifostine during intraoperative peritoneal chemohyperthermia (IPCH) with cisplatin (CDDP) for peritoneal carcinosis. Phase 1 study].
    Vaira M; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Med; 2001 Aug; 92(4):207-11. PubMed ID: 11535965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of cisplatin as intraoperative hyperthermic peritoneal lavage (IHPL) in patients with locally advanced gastric cancer: analysis of pharmacokinetics and of nephrotoxicity.
    Kern W; Braess J; Kotschofsky M; Samel S; Becker H; Hiddemann W; Schleyer E
    Anticancer Res; 2002; 22(5):3099-102. PubMed ID: 12530050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
    Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
    Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer.
    Steller MA; Egorin MJ; Trimble EL; Bartlett DL; Zuhowski EG; Alexander HR; Dedrick RL
    Cancer Chemother Pharmacol; 1999; 43(2):106-14. PubMed ID: 9923815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.